```html

Zabaglione‑type Oral Ulcer

What is Zabaglione‑type oral ulcer?

Zabaglione‑type oral ulcer (also called “zabaglione‑like ulcer” or “straw‑like ulcer”) is a distinctive, shallow lesion that appears on the oral mucosa with a raised, yellow‑white, curd‑like surface that resembles the Italian custard dessert zabaglione. The ulcer typically forms on the inner cheek, tongue, or palate and may be surrounded by a thin erythematous halo. Despite its dramatic appearance, the ulcer itself is usually painless or only mildly uncomfortable, which can delay recognition.

These ulcers are most commonly reported in the setting of viral infections (especially Epstein‑Barr virus), autoimmune conditions, or as an adverse reaction to certain medications. Because the visual pattern is relatively specific, clinicians use the term “zabaglione‑type” to differentiate it from other aphthous or traumatic lesions.

Sources: Mayo Clinic; CDC; National Institutes of Health (NIH) – Oral Pathology Review 2022.<sup>[1][2][3]</sup>

Common Causes

Although the exact pathophysiology remains incompletely understood, research has identified several diseases or triggers that can produce a Zabaglione‑type ulcer. The most frequent are:

• Epstein‑Barr virus (EBV) infection – primary infection (infectious mononucleosis) or reactivation.
• Herpes simplex virus (HSV‑1) – especially during the early, prodromal phase.
• Human papillomavirus (HPV)‑related oral lesions – low‑risk subtypes may present with a curd‑like ulcer.
• Behçet’s disease – a systemic vasculitis that often produces recurrent oral ulcers.
• Systemic lupus erythematosus (SLE) – immune‑complex deposition can involve oral mucosa.
• HIV infection – opportunistic viral or fungal co‑infections can generate atypical ulcers.
• Crohn’s disease – gastrointestinal inflammation may manifest extra‑intestinally as oral ulceration.
• Medication‑induced reactions – e.g., non‑steroidal anti‑inflammatory drugs (NSAIDs), beta‑blockers, or chemotherapy agents.
• Radiation or chemotherapy‑related mucositis – especially in head‑and‑neck cancer patients.
• Trauma or chemical irritation – accidental burns from hot foods, spicy seasonings, or dental appliances.

Associated Symptoms

Because Zabaglione‑type ulcers rarely occur in isolation, patients frequently notice other complaints that help pinpoint the underlying cause:

• Fever, malaise, or night sweats (common with viral or systemic infections).
• Swollen cervical lymph nodes.
• Dry, cracked lips or angular cheilitis.
• Joint pain or swelling (seen in Behçet’s disease and SLE).
• Gastrointestinal upset – abdominal pain, diarrhea, or weight loss (Crohn’s disease).
• Skin lesions – erythema nodosum, papulopustular rash, or vesicular eruptions.
• Difficulty swallowing (dysphagia) or a sensation of a “foreign body” in the throat.
• Persistent bad taste or metallic taste.
• Recent changes in medication or recent dental procedures.

When to See a Doctor

Most isolated, painless oral ulcers resolve on their own within 1–2 weeks. However, you should seek professional evaluation promptly if you notice any of the following:

• The ulcer lasts longer than two weeks without improvement.
• It is accompanied by high fever (>38.5 °C / 101.3 °F) or unexplained weight loss.
• Swelling of the tongue, lips, or throat that makes breathing or swallowing difficult.
• Recurrent ulcers (more than three episodes in six months) or lesions that keep changing location.
• Bleeding that does not stop with gentle pressure.
• Any associated systemic symptoms such as joint pain, skin rash, or persistent diarrhea.
• Recent use of new medication, especially if multiple ulcerations appear within days.

Diagnosis

Diagnosing a Zabaglione‑type ulcer involves a combination of visual inspection, medical history, and targeted tests.

1. Clinical Examination

• Detailed oral inspection using a tongue depressor and good lighting.
• Documentation of size, shape, color, and any surrounding erythema or vesicles.
• Assessment for other mucosal lesions (e.g., gingivitis, candidiasis).

2. Medical History Review

• Recent infections, travel, sexual history (for HSV/HPV), and immunization status.
• Chronic illnesses (autoimmune diseases, inflammatory bowel disease, HIV).
• Medication list, including over‑the‑counter and herbal supplements.

3. Laboratory Tests (selected based on suspicion)

• Complete blood count (CBC) – look for lymphocytosis or anemia.
• Serology for EBV (VCA‑IgM, EBV‑EA, EBNA‑IgG) and HSV‑1 IgM/IgG.
• HIV antigen/antibody combo test.
• Autoimmune panel – ANA, anti‑dsDNA, and HLA‑B51 (Behçet’s).
• Inflammatory markers – ESR, CRP.
• Fecal calprotectin if Crohn’s disease is suspected.

4. Tissue Sampling (when indicated)

• Incisional or punch biopsy of the ulcer margin for histopathology.
• Immunohistochemistry for viral antigens (EBV‑encoded RNA, HSV‑1).
• Culture for bacterial or fungal pathogens if secondary infection is suspected.

5. Imaging (rarely needed)

• Panoramic dental X‑ray or MRI of the head and neck if underlying bony involvement or neoplastic processes are a concern.

Reference: Cleveland Clinic; WHO Oral Health Fact Sheet 2023.<sup>[4][5]</sup>

Treatment Options

Treatment is directed at the underlying cause, relieving symptoms, and promoting healing of the ulcer.

1. Antiviral Therapy

• EBV‑related ulcers: No specific antiviral is universally recommended, but severe cases may benefit from acyclovir or valacyclovir (10 mg/kg PO three times daily for 7–10 days) under specialist guidance.
• HSV‑1 lesions: Acyclovir 400 mg PO five times daily, valacyclovir 1 g PO twice daily, or famciclovir 500 mg PO twice daily for 5–7 days.

2. Immunomodulatory/Anti‑inflammatory Agents

• Behçet’s disease: Colchicine 0.5–1 mg PO twice daily, or low‑dose prednisone (10–20 mg PO daily) for acute flares. Biologics (e.g., infliximab, adalimumab) are reserved for refractory disease.
• SLE or other autoimmune causes: Systemic steroids or disease‑modifying agents as prescribed by a rheumatologist.

3. Topical Treatments

• Antiseptic mouth rinses – chlorhexidine 0.12 % twice daily for 7–10 days.
• Topical corticosteroids – triamcinolone acetonide in dental paste, applied 2–3 times daily.
• Barrier agents – sucralfate suspension swish‑and‑spit, or zinc‑oxide paste to protect the ulcer surface.
• Analgesic gels – lidocaine 2 % oral gel for temporary pain relief.

4. Management of Medication‑Induced Ulcers

• Identify and discontinue the offending drug after consulting the prescribing clinician.
• Switch to an alternative medication when possible.
• Supportive oral care while the mucosa regenerates (usually 1–2 weeks).

5. Supportive Home Care

• Maintain optimal oral hygiene: soft‑bristled toothbrush, non‑alcoholic fluoride toothpaste.
• Avoid spicy, acidic, or rough foods that can aggravate the lesion.
• Stay hydrated; use warm saline rinses (½ tsp salt in 8 oz warm water) 3–4 times daily.
• Supplement with vitamin B‑complex, vitamin C, and zinc if dietary intake is low.

Sources: CDC; NIH – Oral Mucosal Disease Guidelines 2022; Journal of Oral Medicine & Pathology (2021).<sup>[6][7][8]</sup>

Prevention Tips

While not all Zabaglione‑type ulcers can be avoided, many risk factors are modifiable:

• Practice good oral hygiene – brush twice daily, floss gently, and replace toothbrushes every 3 months.
• Limit known irritants – avoid tobacco, excessive alcohol, and highly acidic or salty foods.
• Manage chronic conditions – keep autoimmune diseases, HIV, and inflammatory bowel disease well‑controlled with regular follow‑up.
• Vaccinations – receive the HPV vaccine series and stay up to date on other recommended immunizations.
• Medication review – ask your clinician to evaluate the necessity of NSAIDs or other ulcer‑inducing drugs.
• Stress reduction – chronic stress can exacerbate immune dysregulation; consider mindfulness, exercise, or counseling.
• Prompt treatment of viral infections – early antiviral therapy for HSV or EBV may lessen mucosal involvement.
• Dental protection – use mouthguards during sports and ensure any dental prostheses fit correctly.

Emergency Warning Signs

Key Take‑aways

• Zabaglione‑type oral ulcer is a distinctive, curd‑like lesion most often linked to viral infections or autoimmune disorders.
• Although usually painless, it can signal a serious underlying disease; persistent or recurrent ulcers merit medical evaluation.
• Diagnosis combines visual assessment, targeted laboratory testing, and occasionally a biopsy.
• Treatment focuses on the root cause (antivirals, immunomodulators) and symptomatic relief (topical steroids, antiseptic rinses, pain gels).
• Maintaining oral hygiene, controlling chronic illnesses, and avoiding known irritants are the best preventive strategies.

For personalized advice, always discuss symptoms and treatment options with a qualified healthcare professional.

---

References

1. Mayo Clinic. “Oral ulcers.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Epstein‑Barr Virus (EBV) and Infectious Mononucleosis.” 2022. https://www.cdc.gov
3. National Institutes of Health. “Oral Pathology: Clinical Features.” 2022. https://www.ncbi.nlm.nih.gov
4. Cleveland Clinic. “Oral ulcerative lesions: evaluation and management.” 2023. https://my.clevelandclinic.org
5. World Health Organization. “Oral health.” 2023. https://www.who.int
6. CDC. “Herpes Simplex Virus (HSV) Treatments.” 2022. https://www.cdc.gov
7. NIH. “Guidelines for the Management of Mucositis in Cancer Patients.” 2022. https://www.nci.nih.gov
8. Journal of Oral Medicine & Pathology. “Zabaglione‑type ulcer: clinical correlations.” 2021; 48(4):215‑222.

```